EurekAlert! -
18 Nov 2019 07:00
(American Associates, Ben-Gurion University of the Negev) 'In the future, people who suffer from nighttime AFib may benefit from medications developed to treat people who carry a mutation in this gene,' Prof. Katz says. 'Treating patients based on a genetic understanding of their disease is known as precision medicine.'
Share this Article